Literature DB >> 24125879

A possible association of low pepsinogen I and pepsinogen I/II with low and high body weight in Japanese men.

Ayano Kutsuma1, Haruki Oshida2, Kaname Suwa3, Kei Nakajima4.   

Abstract

BACKGROUND: It is unknown whether low serum pepsinogen I and pepsinogen I/II ratio (PGI-PGI/II), a marker for chronic atrophic gastritis, is associated with low or high body weight.
METHODS: We investigated the association between low PGI-PGI/II and both ends of the spectrum of body mass index (BMI) in 819 apparently healthy Japanese men aged 20-75 years who received a medical check-up in 2008.
RESULTS: In univariate analysis, serum pepsinogen I, but not pepsinogen II or pepsinogen I/II, was significantly reduced across the increasing BMI categories. Multivariate regression analysis showed that, compared with BMI 21.0-22.9 kg/m(2), BMI of 20.9 kg/m(2) and less or 25.0 kg/m(2) and above was significantly associated with low PGI-PGI/II (pepsinogen I<50 ng/ml combined with PG I/II<3.0), even after adjustment for relevant confounders. These associations showed a J-shaped curve against BMI.
CONCLUSION: Low PGI-PGI/II may be independently associated with both low body weight and obesity in Japanese men.
© 2013.

Entities:  

Keywords:  Atrophic gastritis; Low body weight; Obesity; Pepsinogen

Mesh:

Substances:

Year:  2013        PMID: 24125879     DOI: 10.1016/j.clinbiochem.2013.10.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study.

Authors:  Danute Razuka-Ebela; Inese Polaka; Ilva Daugule; Sergei Parshutin; Daiga Santare; Inguna Ebela; Dace Rudzite; Reinis Vangravs; Rolando Herrero; Jin Young Park; Marcis Leja
Journal:  Diagnostics (Basel)       Date:  2022-05-07

2.  Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection.

Authors:  Hee Jin Kim; Nayoung Kim; Hyun Young Kim; Hye Seung Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Do Joong Park; Hyung Ho Kim; Kyoung-Ho Lee; Young-Hoon Kim; Hee Man Kim; Dong Ho Lee
Journal:  Gastric Cancer       Date:  2014-09-21       Impact factor: 7.370

Review 3.  Influence of metabolic syndrome on upper gastrointestinal disease.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Tetsuo Kimura; Koichi Okamoto; Hiroshi Miyamoto; Naoki Muguruma; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-07-02

4.  Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients.

Authors:  Zahra Bahadoran; Parvin Mirmiran; Maryam Zarif-Yeaganeh; Homayoun Zojaji; Fereidoun Azizi
Journal:  Endocrinol Metab (Seoul)       Date:  2015-05-18

5.  High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis.

Authors:  Miwa Kawanaka; Tomohiro Tanikawa; Tomoari Kamada; Katusinori Ishii; Noriyo Urata; Jun Nakamura; Ken Nishino; Mitsuhiko Suehiro; Takako Sasai; Noriaki Manabe; Yasumasa Monobe; Hirofumi Kawamoto; Ken Haruma
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

6.  Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects.

Authors:  Hong Yu; Ying Liu; Shujing Jiang; Yunfeng Zhou; Zheng Guan; Siyuan Dong; Fong-Fong Chu; Chunbo Kang; Qiang Gao
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.